InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,460.48
(
-0.41%
)
US TECH 100
19,184.00
(
-0.42%
)
Dow Jones
39,118.86
(
-0.12%
)
Brent Oil
84.85
(
-0.66%
)
Bitcoin
60,277.14
(
-2.16%
)
Post# of 252426
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 832
Posts 119954
Boards Moderated 17
Alias Born 09/05/2002

DewDiligence

Member Level

Re: jq1234 post# 117617

Monday, 04/11/2011 1:06:38 PM

Monday, April 11, 2011 1:06:38 PM

Post# of 252426
MRK inks branded-generics deal for emerging markets with India’s Sun Pharma:

http://finance.yahoo.com/news/Merck-Co-Inc-and-Sun-Pharma-bw-2289043827.html?x=0

Financial terms were not disclosed.

The Global Demographic Tailwind, which manifests itself via escalating sales of branded generics in emerging markets, has become the most important growth driver for the global pharmaceutical industry.

See #msg-61699995, #msg-59590951, #msg-48556414, and #msg-50473238 for related info.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up